Publication Date
March 2024
USD 796.09 million
USD 1,575.32 million
USD 876.87 million
Antithrombin Market by Formulation (Liquid, Lyophilized), Source (Goat Milk, Human), Type, Route, Application - Global Forecast 2024-2030

[180 Pages Report] The Antithrombin Market size was estimated at USD 796.09 million in 2023 and expected to reach USD 876.87 million in 2024, at a CAGR 10.24% to reach USD 1,575.32 million by 2030.

Antithrombin Market
To learn more about this report, request a free sample copy
Antithrombin Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Antithrombin Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Antithrombin Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Antithrombin Market, highlighting leading vendors and their innovative profiles. These include Bio-Techne Corporation, BioPharm Laboratories, LLC, CSL Limited, Diapharma Group, Inc., European Medicines Agency, Genesis BioPharma, Grifols, S.A., Kedrion S.p.A., Lee Biosolutions, Inc., LFB USA, Inc., Merck KGaA, Octapharma AG, Scripps Laboratories, Inc., Siemens AG, SK Plasma, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., and WebMD, LLC.

Market Segmentation & Coverage

This research report categorizes the Antithrombin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Liquid
    • Lyophilized
  • Source
    • Goat Milk
    • Human
  • Type
    • Anticoagulant
    • Antiplatelet
    • Thrombolytic Drugs
  • Route
    • Oral
    • Parenteral
  • Application
    • Diagnostics
    • Research
    • Therapeutics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Antithrombin Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Antithrombin Market?
  3. What are the technology trends and regulatory frameworks in the Antithrombin Market?
  4. What is the market share of the leading vendors in the Antithrombin Market?
  5. Which modes and strategic moves are suitable for entering the Antithrombin Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Antithrombin Market, by Formulation
  7. Antithrombin Market, by Source
  8. Antithrombin Market, by Type
  9. Antithrombin Market, by Route
  10. Antithrombin Market, by Application
  11. Americas Antithrombin Market
  12. Asia-Pacific Antithrombin Market
  13. Europe, Middle East & Africa Antithrombin Market
  14. Competitive Landscape
  15. Competitive Portfolio
Companies Mentioned
  • Bio-Techne Corporation
  • BioPharm Laboratories, LLC
  • CSL Limited
  • Diapharma Group, Inc.
  • European Medicines Agency
  • Genesis BioPharma
  • Grifols, S.A.
  • Kedrion S.p.A.
  • Lee Biosolutions, Inc.
  • LFB USA, Inc.
  • Merck KGaA
  • Octapharma AG
  • Scripps Laboratories, Inc.
  • Siemens AG
  • SK Plasma
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • WebMD, LLC
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Antithrombin Market
The Global Antithrombin Market size was estimated at USD 796.09 million in 2023 and expected to reach USD 876.87 million in 2024.
The Global Antithrombin Market to grow USD 1,575.32 million by 2030, at a CAGR of 10.24%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.